4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001013762-23-001300
Chief Financial Officer acquired 62,972 shares (conversion)
- Chief Financial Officer returned 62,972 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bodenstedt Matthias Chief Financial Officer | 2023-10-01 | Conversion | +62,972 | 620,903 | D | ||
| Bodenstedt Matthias Chief Financial Officer | 2023-10-01 | Returned to the company | −62,972 | 294,473 | D | ||
| Derivatives | |||||||
| Bodenstedt Matthias Chief Financial Officer | 2023-10-01 | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,872 | 8,754 | D | ||
Loading xslF345X05/ownership.xml…